PIOEASE 7.5

PIOEASE 7.5 by Voithea Healthcare is a trusted anti-diabetic formulation containing Pioglitazone 7.5mg, designed to improve insulin sensitivity and regulate blood glucose levels in patients with type 2 diabetes mellitus.

Pioglitazone belongs to the thiazolidinedione class and works by enhancing the body’s response to insulin without increasing insulin secretion. This helps in lowering blood sugar levels effectively while reducing the risk of hypoglycemia. PIOEASE 7.5 is especially beneficial for patients who require long-term glycemic control with improved metabolic outcomes.

By offering a low-dose option with a strong safety and efficacy profile, PIOEASE 7.5 reflects Voithea Healthcare’s commitment to accessible, precise, and patient-centric diabetic care.